BNTC (STOCKS)
Benitec Biopharma Inc. Common Stock
$11.560000
-0.140000 (-1.20%)
Prev close: $11.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jerel A. Banks
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $391.45M
- Employees
- 19
- P/E (TTM)
- -11.64
- P/B (TTM)
- 3.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q1)
|
$-0.22 | $-0.38 | +0.1557 | +41.44% |
|
Jun 2025 (Q4)
|
$-0.42 | $-0.30 | -0.1242 | -41.99% |
|
Mar 2025 (Q3)
|
$-0.24 | $-0.35 | +0.1148 | +32.36% |
|
Dec 2024 (Q2)
|
$-0.33 | $-0.79 | +0.4551 | +57.97% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $3.95M |
| Operating Expenses | $38.44M |
| Research and Development | $17.29M |
| Other Operating Expenses | $21.15M |
| Operating Income/Loss | -$38.44M |
| Income/Loss From Continuing Operations After Tax | -$34.48M |
| Income/Loss From Continuing Operations Before Tax | -$34.48M |
| Net Income/Loss | -$34.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$34.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$34.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.00 |
| Diluted Earnings Per Share | -$1.00 |
| Basic Average Shares | 143,357,324 |
| Diluted Average Shares | 143,357,324 |
| Assets | $96.03M |
| Current Assets | $95.08M |
| Prepaid Expenses | $499.00K |
| Other Current Assets | $94.58M |
| Noncurrent Assets | $948.00K |
| Fixed Assets | $118.00K |
| Other Non-current Assets | $830.00K |
| Liabilities | $2.43M |
| Current Liabilities | $2.03M |
| Wages | $463.00K |
| Other Current Liabilities | $1.56M |
| Noncurrent Liabilities | $403.00K |
| Equity | $93.60M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $93.60M |
| Liabilities And Equity | $96.03M |
| Net Cash Flow From Operating Activities | -$22.35M |
| Net Cash Flow From Operating Activities, Continuing | -$22.35M |
| Net Cash Flow From Investing Activities | $17.05M |
| Net Cash Flow From Financing Activities | $48.83M |
| Net Cash Flow | $43.53M |
| Net Cash Flow, Continuing | $43.53M |
| Comprehensive Income/Loss | -$34.54M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$34.24M |
| Other Comprehensive Income/Loss | -$27.19M |
| Other Comprehensive Income/Loss Attributable To Parent | $243.00K |